Calendar1 Calendar2 single-blue-chevron-left single-chevron-gray-left Asset 1 Office double-blue-chevron-left Light Commercial Self Performed Building Self-Performed Services Signature single-blue-chevron-left BigD-Facebook BigD-Instagram BigD-LinkedIn BigD-Twitter
Project Myriad Genetics and Laboratories Phase V
Owner


Project Size

79,822 sq ft

Project Dates

18 months

Project Location

305 S Chipeta Way Salt Lake City, UT

Founded in 1991, Myriad Genetics has emerged as a world leader in the discovery and sequencing of disease-related genes and the elucidation of their biochemical pathways.

Project Description

The project included a three-story, 79,822 square-foot, steel-framed building and a 90,923 square-foot parking garage to support Myriad Genetics’ biopharmaceutical research and development. The project includes exterior-facing private-office space with centrally located open lab space within. Office features include a conference room with multi-media capabilities, a small lobby, break rooms and general storage space. Laboratory elements include 34 fume hoods, nine canopies and multiple computer rooms. Also included is a biological safety level (BSL) 2+ laboratory, which incorporates many advanced biological containment safety features. Sustainable design elements consisted of two rainwater-capture cisterns for the prevention of storm water runoff pollution.

Founded in 1991, Myriad Genetics has emerged as a world leader in the discovery and sequencing of disease-related genes and the elucidation of their biochemical pathways. Myriad continues to develop and commercialize medical tests made possible by their ground-breaking gene and protein discoveries including the BRCA1 and BRCA2 breast cancer genes. Going forward, Myriad is uniquely positioned to develop and commercialize new medical tests to prevent or mitigate the toll of mankind’s deadliest diseases. Myriad Genetics is a biopharmaceutical company focused on the development of novel healthcare products. In addition to an expanding preclinical pipeline, their drug discovery and development is strong in the areas of cancer and antivirals.

This project was challenging due to restricted free space on the job site. This was due to the close proximity (30 feet) between the existing Myriad Genetics building and the new facility. As there was no available room for lay downs, trailers or parking, extra planning was required to support project logistics. Additionally, extra diligence was required to protect existing utility lines, which ran through the underground parking structure’s excavation area.